135 related articles for article (PubMed ID: 7204877)
1. [Clinical trials of prophylaxis of toxoplasmic retinochoroiditis recurrences by immunotherapy using B.C.G. (author's transl)].
Bonnet M; Garin JP; La Falce E
J Fr Ophtalmol; 1980; 3(11):653-5. PubMed ID: 7204877
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
Fernandes Felix JP; Cavalcanti Lira RP; Cosimo AB; Cardeal da Costa RL; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2016 Oct; 170():176-182. PubMed ID: 27521607
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial.
Felix JP; Lira RP; Zacchia RS; Toribio JM; Nascimento MA; Arieta CE
Am J Ophthalmol; 2014 Apr; 157(4):762-766.e1. PubMed ID: 24388839
[TBL] [Abstract][Full Text] [Related]
4. Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Fernandes Felix JP; Cavalcanti Lira RP; Grupenmacher AT; Assis Filho HLG; Cosimo AB; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2020 May; 213():195-202. PubMed ID: 31926883
[TBL] [Abstract][Full Text] [Related]
5. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
Peacock JE; Greven CM; Cruz JM; Hurd DD
Bone Marrow Transplant; 1995 Jun; 15(6):983-7. PubMed ID: 7581102
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
Timsit JC; Bloch-Michel E
J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056
[TBL] [Abstract][Full Text] [Related]
7. Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy.
Heringer GC; Oueghlani E; Dell'Omo R; Curi AL; Oréfice F; Pavésio CE
Br J Ophthalmol; 2014 Sep; 98(9):1218-20. PubMed ID: 24820044
[TBL] [Abstract][Full Text] [Related]
8. Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia.
de-la-Torre A; Rios-Cadavid AC; Cardozo-García CM; Gomez-Marín JE
Br J Ophthalmol; 2009 Aug; 93(8):1001-4. PubMed ID: 19429576
[TBL] [Abstract][Full Text] [Related]
9. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
Psilas K; Petroutsos G; Aspiotis M
J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846
[TBL] [Abstract][Full Text] [Related]
11. [Interest in treatment with subconjunctival clindamycin in toxoplasmic retinochoroiditis].
Ben Zina Z; Abid D; Kharrat W; Chaker N; Aloulou K; Chaâbouni M
Tunis Med; 2001 Mar; 79(3):157-60. PubMed ID: 11471444
[TBL] [Abstract][Full Text] [Related]
12. Effect of immunization with attenuated Mycobacterium bovis on experimental toxoplasmic retinochoroiditis.
Tabbara KJ; O'Connor GR; Nozik RA
Am J Ophthalmol; 1975 Apr; 79(4):641-7. PubMed ID: 1119523
[TBL] [Abstract][Full Text] [Related]
13. [Toxoplasmic chorioretinitis complicated by retinal detachment].
Frau E; Gregoire-Cassoux N; Lautier-Frau M; Labetoulle M; Lehoang P; Offret H
J Fr Ophtalmol; 1997; 20(10):749-52. PubMed ID: 9587588
[TBL] [Abstract][Full Text] [Related]
14. Failure of systemic oral doxycycline in preventing ocular toxoplasmic retinochoroiditis in French military personnel.
Saad S; Delbarre M; Saad R; Berguiga M; Benisty D; Marechal M; Adam T; Froussart F
J R Army Med Corps; 2018 May; 164(2):122-123. PubMed ID: 29317472
[TBL] [Abstract][Full Text] [Related]
15. [Congenital ocular toxoplasmosis and late recurrences (author's transl)].
François J
J Fr Ophtalmol; 1981; 4(2):157-65. PubMed ID: 7240657
[TBL] [Abstract][Full Text] [Related]
16. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis.
Montoya JG; Parmley S; Liesenfeld O; Jaffe GJ; Remington JS
Ophthalmology; 1999 Aug; 106(8):1554-63. PubMed ID: 10442904
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Real-time PCR-based assay using the lightcycler system for detection of Toxoplasma gondii bradyzoite genes in blood specimens from patients with toxoplasmic retinochoroiditis.
Contini C; Seraceni S; Cultrera R; Incorvaia C; Sebastiani A; Picot S
Int J Parasitol; 2005 Mar; 35(3):275-83. PubMed ID: 15722079
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
[TBL] [Abstract][Full Text] [Related]
19. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
20. Recurrent toxoplasmic retinochoroiditis after clindamycin: a case report.
Murphy GE
Ann Ophthalmol; 1982 Jul; 14(7):632-3. PubMed ID: 7125453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
